Nadia Traficante
The University of Melbourne(AU)Peter MacCallum Cancer Centre(AU)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Cancer Genomics and Diagnostics, PARP inhibition in cancer therapy, Ferroptosis and cancer prognosis, Cancer-related molecular mechanisms research
Most-Cited Works
- → Whole–genome characterization of chemoresistant ovarian cancer(2015)1,618 cited
- → Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome(2008)1,499 cited
- → Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas(2009)301 cited
- → Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma(2018)282 cited
- → The molecular origin and taxonomy of mucinous ovarian carcinoma(2019)183 cited
- → Prognostic gene expression signature for high-grade serous ovarian cancer(2020)170 cited
- → Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D(2020)159 cited
- → A binding motif for Siah ubiquitin ligase(2003)150 cited
- → Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-α signaling(2001)137 cited
- → Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors(2008)129 cited